PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.095 per Share
Sep 05, 2017 20:05 pm UTC| Business
NEW YORK, Sept. 05, 2017 -- PennantPark Floating Rate Capital Ltd. (the "Company") (NASDAQ:PFLT) declares monthly distribution for September 2017 of $0.095 per share, payable on October 2, 2017 to stockholders of record...
Raytheon Australia Opens Its Next Generation Customer Engagement Centre
Sep 05, 2017 20:02 pm UTC| Business
Marshalltown, IA, Sept. 05, 2017 -- Last week Raytheon Australia opened the doors to their next-generation Customer Engagement Centre at their corporate headquarters in Canaberra. The grand opening featured a guided...
Sep 05, 2017 20:01 pm UTC| Business
FREMONT, Calif., Sept. 05, 2017 -- Electronics For Imaging (Nasdaq:EFII) announced that Complete Design Packaging (CDP), an independent corrugated packaging provider based in Concord, N.C., will be the first business...
Insmed Announces Proposed Public Offering of Common Stock
Sep 05, 2017 20:01 pm UTC| Business
BRIDGEWATER, N.J., Sept. 05, 2017 -- Insmed Incorporated (Nasdaq:INSM) announced today that it has commenced an underwritten public offering of $250 million of shares of its common stock. All of the shares of common...
Trevena to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Sep 05, 2017 20:01 pm UTC| Business
CHESTERBROOK, Pa., Sept. 05, 2017 -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will be presenting at the 19th Annual Global Investment Conference hosted by Rodman Renshaw on Tuesday, September 12, 2017, at...
Depomed to Present at the Morgan Stanley Global Healthcare Conference
Sep 05, 2017 20:01 pm UTC| Business
NEWARK, Calif. , Sept. 05, 2017 -- Depomed, Inc. (NASDAQ:DEPO) today announced that its senior management will participate in a fireside chat at the 2017 Morgan Stanley Global Healthcare Conference scheduled for 4:40 pm...
Endocyte Announces Presentation at the European Society for Medical Oncology (ESMO)
Sep 05, 2017 20:01 pm UTC| Business
WEST LAFAYETTE, Ind., Sept. 05, 2017 -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that a...